Leerink and TD Cowen are acting as joint book running managers for the offering. The deal size was increased to $300M from $250M and priced below last closing price of $42.85.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNA:
- Closing Bell Movers: Flutter jumps 10% on earnings, guidance raise
- Avidity Biosciences announces $250M common stock offering
- Biotech Alert: Searches spiking for these stocks today
- Avidity Biosciences Reports Second Quarter 2024 Financial Results and Recent Highlights
- Avidity Biosciences price target raised to $60 from $45 at Chardan